U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C15H21NO2
Molecular Weight 247.3327
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of MEPERIDINE

SMILES

CCOC(=O)C1(CCN(C)CC1)C2=CC=CC=C2

InChI

InChIKey=XADCESSVHJOZHK-UHFFFAOYSA-N
InChI=1S/C15H21NO2/c1-3-18-14(17)15(9-11-16(2)12-10-15)13-7-5-4-6-8-13/h4-8H,3,9-12H2,1-2H3

HIDE SMILES / InChI

Description
Curator's Comment: description was created based on several sources, including: http://www.pbm.va.gov/clinicalguidance/criteriaforuse/MeperidineCriteriaforUse.pdf | https://www.drugs.com/pro/meperidine.html

Pethidine, also known as meperidine and Demerol, a narcotic analgesic that can be used for the relief of most types of moderate to severe pain, including postoperative pain and the pain of labor. Meperidine is an opioid agonist with multiple actions qualitatively similar to those of morphine. Most common adverse reactions were lightheadedness, dizziness, sedation, nausea, vomiting, and sweating. Pethidine has serious interactions that can be dangerous with monoamine oxidase inhibitors (e.g., furazolidone, isocarboxazid, moclobemide, phenelzine, procarbazine, selegiline, tranylcypromine). Pethidine can interact with muscle relaxants, some antidepressants, benzodiazepines, and ethanol.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
450.1 nM [Ki]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
DEMEROL

Approved Use

For the relief of moderate to severe pain. For preoperative medication. For support of anesthesia. For obstetrical analgesia.

Launch Date

-8.5656961E11
Cmax

Cmax

ValueDoseCo-administeredAnalytePopulation
196 ng/mL
30 mg single, intravenous
dose: 30 mg
route of administration: Intravenous
experiment type: SINGLE
co-administered:
MEPERIDINE plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
AUC

AUC

ValueDoseCo-administeredAnalytePopulation
19.6 μg × min/mL
30 mg single, intravenous
dose: 30 mg
route of administration: Intravenous
experiment type: SINGLE
co-administered:
MEPERIDINE plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
T1/2

T1/2

ValueDoseCo-administeredAnalytePopulation
124 min
30 mg single, intravenous
dose: 30 mg
route of administration: Intravenous
experiment type: SINGLE
co-administered:
MEPERIDINE plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
Doses

Doses

DosePopulationAdverse events​
10 g single, oral
Overdose
Dose: 10 g
Route: oral
Route: single
Dose: 10 g
Sources:
unknown, 17 years
Health Status: unknown
Age Group: 17 years
Sex: F
Sources:
Other AEs: Myoclonus, Hyperreflexia...
Other AEs:
Myoclonus (1 patient)
Hyperreflexia (1 patient)
Respiratory depression (1 patient)
Hypotension (1 patient)
Tremor (1 patient)
Sources:
50 mg single, intrathecal
Dose: 50 mg
Route: intrathecal
Route: single
Dose: 50 mg
Sources:
unknown, 24 - 81 years
Health Status: unknown
Age Group: 24 - 81 years
Sex: F
Sources:
Other AEs: Respiratory depression...
Other AEs:
Respiratory depression (2 patients)
Sources:
1000 mg 1 times / day multiple, intramuscular
Highest studied dose
Dose: 1000 mg, 1 times / day
Route: intramuscular
Route: multiple
Dose: 1000 mg, 1 times / day
Sources:
unhealthy, 37 years
n = 1
Health Status: unhealthy
Condition: pain
Age Group: 37 years
Sex: M
Population Size: 1
Sources:
Disc. AE: Muscle twitching, Tremor...
AEs leading to
discontinuation/dose reduction:
Muscle twitching (1 patient)
Tremor (1 patient)
Sources:
600 mg 1 times / day multiple, intravenous
Highest studied dose
Dose: 600 mg, 1 times / day
Route: intravenous
Route: multiple
Dose: 600 mg, 1 times / day
Sources:
unknown, 44 years
n = 7
Health Status: unknown
Age Group: 44 years
Sex: M+F
Population Size: 7
Sources:
Other AEs: Jitteriness, Hallucinations...
Other AEs:
Jitteriness (3 patients)
Hallucinations (3 patients)
Seizures (3 patients)
Sources:
50 mg 6 times / day multiple, intramuscular
Recommended
Dose: 50 mg, 6 times / day
Route: intramuscular
Route: multiple
Dose: 50 mg, 6 times / day
Sources:
pregnant, adult
Health Status: pregnant
Age Group: adult
Sex: F
Sources:
Other AEs: Withdrawal syndrome neonatal...
50 mg 6 times / day multiple, oral
Recommended
Dose: 50 mg, 6 times / day
Route: oral
Route: multiple
Dose: 50 mg, 6 times / day
Sources:
pregnant, adult
Health Status: pregnant
Condition: pain
Age Group: adult
Sex: F
Sources:
Other AEs: Withdrawal syndrome neonatal...
50 mg 6 times / day multiple, subcutaneous
Recommended
Dose: 50 mg, 6 times / day
Route: subcutaneous
Route: multiple
Dose: 50 mg, 6 times / day
Sources:
pregnant, adult
Health Status: pregnant
Age Group: adult
Sex: F
Sources:
Other AEs: Withdrawal syndrome neonatal...
50 mg 6 times / day multiple, intramuscular
Recommended
Dose: 50 mg, 6 times / day
Route: intramuscular
Route: multiple
Dose: 50 mg, 6 times / day
Sources:
unhealthy, adult
Health Status: unhealthy
Condition: pain
Age Group: adult
Sources:
Other AEs: Addiction, Respiratory depression...
Other AEs:
Addiction
Respiratory depression (serious|grade 5)
Sources:
50 mg 6 times / day multiple, oral
Recommended
Dose: 50 mg, 6 times / day
Route: oral
Route: multiple
Dose: 50 mg, 6 times / day
Sources:
unhealthy, adult
Health Status: unhealthy
Condition: pain
Age Group: adult
Sources:
Other AEs: Addiction, Respiratory depression...
Other AEs:
Addiction
Respiratory depression (serious|grade 5)
Sources:
50 mg 6 times / day multiple, subcutaneous
Recommended
Dose: 50 mg, 6 times / day
Route: subcutaneous
Route: multiple
Dose: 50 mg, 6 times / day
Sources:
unhealthy, adult
Health Status: unhealthy
Condition: pain
Age Group: adult
Sources:
Other AEs: Addiction, Respiratory depression...
Other AEs:
Addiction
Respiratory depression (serious|grade 5)
Sources:
10 mg/mL multiple, intravenous
Recommended
Dose: 10 mg/mL
Route: intravenous
Route: multiple
Dose: 10 mg/mL
Sources:
pregnant, adult
Health Status: pregnant
Age Group: adult
Sex: F
Sources:
Other AEs: Withdrawal syndrome neonatal...
10 mg/mL multiple, intravenous
Recommended
Dose: 10 mg/mL
Route: intravenous
Route: multiple
Dose: 10 mg/mL
Sources:
unhealthy, adult
Other AEs: Addiction, Respiratory depression...
Other AEs:
Addiction
Respiratory depression (serious|grade 5)
Sources:
AEs

AEs

AESignificanceDosePopulation
Hyperreflexia 1 patient
10 g single, oral
Overdose
Dose: 10 g
Route: oral
Route: single
Dose: 10 g
Sources:
unknown, 17 years
Health Status: unknown
Age Group: 17 years
Sex: F
Sources:
Hypotension 1 patient
10 g single, oral
Overdose
Dose: 10 g
Route: oral
Route: single
Dose: 10 g
Sources:
unknown, 17 years
Health Status: unknown
Age Group: 17 years
Sex: F
Sources:
Myoclonus 1 patient
10 g single, oral
Overdose
Dose: 10 g
Route: oral
Route: single
Dose: 10 g
Sources:
unknown, 17 years
Health Status: unknown
Age Group: 17 years
Sex: F
Sources:
Respiratory depression 1 patient
10 g single, oral
Overdose
Dose: 10 g
Route: oral
Route: single
Dose: 10 g
Sources:
unknown, 17 years
Health Status: unknown
Age Group: 17 years
Sex: F
Sources:
Tremor 1 patient
10 g single, oral
Overdose
Dose: 10 g
Route: oral
Route: single
Dose: 10 g
Sources:
unknown, 17 years
Health Status: unknown
Age Group: 17 years
Sex: F
Sources:
Respiratory depression 2 patients
50 mg single, intrathecal
Dose: 50 mg
Route: intrathecal
Route: single
Dose: 50 mg
Sources:
unknown, 24 - 81 years
Health Status: unknown
Age Group: 24 - 81 years
Sex: F
Sources:
Muscle twitching 1 patient
Disc. AE
1000 mg 1 times / day multiple, intramuscular
Highest studied dose
Dose: 1000 mg, 1 times / day
Route: intramuscular
Route: multiple
Dose: 1000 mg, 1 times / day
Sources:
unhealthy, 37 years
n = 1
Health Status: unhealthy
Condition: pain
Age Group: 37 years
Sex: M
Population Size: 1
Sources:
Tremor 1 patient
Disc. AE
1000 mg 1 times / day multiple, intramuscular
Highest studied dose
Dose: 1000 mg, 1 times / day
Route: intramuscular
Route: multiple
Dose: 1000 mg, 1 times / day
Sources:
unhealthy, 37 years
n = 1
Health Status: unhealthy
Condition: pain
Age Group: 37 years
Sex: M
Population Size: 1
Sources:
Hallucinations 3 patients
600 mg 1 times / day multiple, intravenous
Highest studied dose
Dose: 600 mg, 1 times / day
Route: intravenous
Route: multiple
Dose: 600 mg, 1 times / day
Sources:
unknown, 44 years
n = 7
Health Status: unknown
Age Group: 44 years
Sex: M+F
Population Size: 7
Sources:
Jitteriness 3 patients
600 mg 1 times / day multiple, intravenous
Highest studied dose
Dose: 600 mg, 1 times / day
Route: intravenous
Route: multiple
Dose: 600 mg, 1 times / day
Sources:
unknown, 44 years
n = 7
Health Status: unknown
Age Group: 44 years
Sex: M+F
Population Size: 7
Sources:
Seizures 3 patients
600 mg 1 times / day multiple, intravenous
Highest studied dose
Dose: 600 mg, 1 times / day
Route: intravenous
Route: multiple
Dose: 600 mg, 1 times / day
Sources:
unknown, 44 years
n = 7
Health Status: unknown
Age Group: 44 years
Sex: M+F
Population Size: 7
Sources:
Withdrawal syndrome neonatal
50 mg 6 times / day multiple, intramuscular
Recommended
Dose: 50 mg, 6 times / day
Route: intramuscular
Route: multiple
Dose: 50 mg, 6 times / day
Sources:
pregnant, adult
Health Status: pregnant
Age Group: adult
Sex: F
Sources:
Withdrawal syndrome neonatal
50 mg 6 times / day multiple, oral
Recommended
Dose: 50 mg, 6 times / day
Route: oral
Route: multiple
Dose: 50 mg, 6 times / day
Sources:
pregnant, adult
Health Status: pregnant
Condition: pain
Age Group: adult
Sex: F
Sources:
Withdrawal syndrome neonatal
50 mg 6 times / day multiple, subcutaneous
Recommended
Dose: 50 mg, 6 times / day
Route: subcutaneous
Route: multiple
Dose: 50 mg, 6 times / day
Sources:
pregnant, adult
Health Status: pregnant
Age Group: adult
Sex: F
Sources:
Addiction
50 mg 6 times / day multiple, intramuscular
Recommended
Dose: 50 mg, 6 times / day
Route: intramuscular
Route: multiple
Dose: 50 mg, 6 times / day
Sources:
unhealthy, adult
Health Status: unhealthy
Condition: pain
Age Group: adult
Sources:
Respiratory depression serious|grade 5
50 mg 6 times / day multiple, intramuscular
Recommended
Dose: 50 mg, 6 times / day
Route: intramuscular
Route: multiple
Dose: 50 mg, 6 times / day
Sources:
unhealthy, adult
Health Status: unhealthy
Condition: pain
Age Group: adult
Sources:
Addiction
50 mg 6 times / day multiple, oral
Recommended
Dose: 50 mg, 6 times / day
Route: oral
Route: multiple
Dose: 50 mg, 6 times / day
Sources:
unhealthy, adult
Health Status: unhealthy
Condition: pain
Age Group: adult
Sources:
Respiratory depression serious|grade 5
50 mg 6 times / day multiple, oral
Recommended
Dose: 50 mg, 6 times / day
Route: oral
Route: multiple
Dose: 50 mg, 6 times / day
Sources:
unhealthy, adult
Health Status: unhealthy
Condition: pain
Age Group: adult
Sources:
Addiction
50 mg 6 times / day multiple, subcutaneous
Recommended
Dose: 50 mg, 6 times / day
Route: subcutaneous
Route: multiple
Dose: 50 mg, 6 times / day
Sources:
unhealthy, adult
Health Status: unhealthy
Condition: pain
Age Group: adult
Sources:
Respiratory depression serious|grade 5
50 mg 6 times / day multiple, subcutaneous
Recommended
Dose: 50 mg, 6 times / day
Route: subcutaneous
Route: multiple
Dose: 50 mg, 6 times / day
Sources:
unhealthy, adult
Health Status: unhealthy
Condition: pain
Age Group: adult
Sources:
Withdrawal syndrome neonatal
10 mg/mL multiple, intravenous
Recommended
Dose: 10 mg/mL
Route: intravenous
Route: multiple
Dose: 10 mg/mL
Sources:
pregnant, adult
Health Status: pregnant
Age Group: adult
Sex: F
Sources:
Addiction
10 mg/mL multiple, intravenous
Recommended
Dose: 10 mg/mL
Route: intravenous
Route: multiple
Dose: 10 mg/mL
Sources:
unhealthy, adult
Respiratory depression serious|grade 5
10 mg/mL multiple, intravenous
Recommended
Dose: 10 mg/mL
Route: intravenous
Route: multiple
Dose: 10 mg/mL
Sources:
unhealthy, adult
Overview

Overview

CYP3A4CYP2C9CYP2D6hERG


OverviewOther

Other InhibitorOther SubstrateOther Inducer


Drug as victim

Drug as victim

TargetModalityActivityMetaboliteClinical evidence
yes
yes
likely (co-administration study)
Comment: The concomitant use of DEMEROL Injection and CYP3A4 or CYP2B6 inhibitors can increase the plasma concentration of meperidine, resulting in increased or prolonged opioid effects; The concomitant use of DEMEROL Injection and CYP3A4 inducers, or CYP2B6 inducers can decrease the plasma concentration of meperidine
Page: 20.0
yes
likely (co-administration study)
Comment: The concomitant use of DEMEROL Injection and CYP3A4 or CYP2B6 inhibitors can increase the plasma concentration of meperidine, resulting in increased or prolonged opioid effects; The concomitant use of DEMEROL Injection and CYP3A4 inducers, or CYP2B6 inducers can decrease the plasma concentration of meperidine
Page: 20.0
Tox targets

Tox targets

TargetModalityActivityMetaboliteClinical evidence
PubMed

PubMed

TitleDatePubMed
Pseudotumor cerebri induced by all-trans-retinoic acid in a child treated for acute promyelocytic leukemia.
2000 Apr
[Meperidine (pethidine) outdated as analgesic in acute pancreatitis].
2000 Apr 1
[Condition of patients after surgical wisdom tooth extraction under general anesthesia with different premedication variants--a prospective study based on a post-anesthesia questionnaire].
2001
Sedation and analgesia for transvaginal oocyte retrieval: an audit resulting in a change of clinical practice.
2001
Analgesic efficacy of tramadol 2 mg kg(-1) for paediatric day-case adenoidectomy.
2001 Apr
Tramadol for postoperative shivering: a double-blind comparison with pethidine.
2001 Apr
Co-administration of drugs and blood products.
2001 Apr
Intrathecal pethidine as sole anaesthetic agent for operative procedures of the lower limb, inguinal area and perineum.
2001 Dec
Morphine, pethidine and buprenorphine disposition in the cat.
2001 Dec
[Comparison of vaginal misoprostol and oxytocin for labor induction in post-term pregnancy].
2001 Dec
A randomized comparison of low-dose ketamine and lignocaine infiltration with ketamine-diazepam anaesthesia for post partum tubal ligation in Vanuatu.
2001 Feb
[Evaluation of analgesia after cesarean section].
2001 Jul-Aug
Post operative pain therapy: a survey of prescribing patterns and adequacy of analgesia in Ibadan, Nigeria.
2001 Mar
Maternal analgesia during labor disturbs newborn behavior: effects on breastfeeding, temperature, and crying.
2001 Mar
Prospective, randomized trial comparing diathermy and Harmonic Scalpel hemorrhoidectomy.
2001 May
Influence of doxepin used in preemptive analgesia on the nociception in the perioperative period. Experimental and clinical study.
2001 May-Jun
[Prospective double-blind randomized trial of cryoanalgesia: experimental and clinical study].
2001 Nov
Upper and mid-ureteric stones: a prospective unrandomized comparison of retroperitoneoscopic and open ureterolithotomy.
2001 Nov
Clinical experience and results of ESWL treatment for 3,093 urinary calculi with the Storz Modulith SL 20 lithotripter at the Singapore general hospital.
2002
Prevention and treatment of respiratory syncytial virus bronchiolitis and postbronchiolitic wheezing.
2002
A placebo-controlled, randomized trial of droperidol versus metoclopramide for outpatients undergoing gynecological laparoscopy under conscious sedation.
2002 Apr
Laparoscopic hysterectomy versus abdominal hysterectomy: a controlled study of clinical and functional outcomes.
2002 Aug
Pulmonary function in infants exposed to pethidine.
2002 Aug
Selegiline: a second look. Six years later: too risky in Parkinson's disease.
2002 Aug
Noninvasive anesthesia, analgesia and radiation-free extracorporeal shock wave lithotripsy for stones in the most distal ureter: experience with 165 patients.
2002 Aug
Leptospirosis: skin wounds and control strategies, Thailand, 1999.
2002 Dec
Intraperitoneal pethidine versus intramuscular pethidine for the relief of pain after laparoscopic cholecystectomy: randomized trial.
2002 Dec
Vitamin K and childhood cancer: analysis of individual patient data from six case-control studies.
2002 Jan 7
The management of metastatic bone pain in a developing country: the role of radiotherapy as an adjunct to weak opioids.
2002 Jan-Feb
Mini cholecystectomy now a day stay surgery: anaesthetic management with multi modal analgesia.
2002 Jul
Severe hypokalaemia secondary to dicloxacillin.
2002 Jul
A thermal threshold testing device for evaluation of analgesics in cats.
2002 Jun
Intra-arterial injection of metoclopramide, midazolam, propofol and pethidine.
2002 Jun
Double-blind, randomized trial comparing Harmonic Scalpel hemorrhoidectomy, bipolar scissors hemorrhoidectomy, and scissors excision: ligation technique.
2002 Jun
Treatment patterns of isolated benign headache in US emergency departments.
2002 Mar
Liquid-phase microextraction of protein-bound drugs under non-equilibrium conditions.
2002 May
Transdermal fentanyl for the management of acute pancreatitis pain.
2002 May
Next generation of everyday analgesics.
2002 May-Jun
Plication darn for the repair of inguinal hernia. A university hospital experience.
2002 Nov
Comparison of intravenous ketorolac and meperidine in the treatment of biliary colic.
2002 Oct
The low normothermia concept--maintaining a core body temperature between 36 and 37 degrees C in acute stroke unit patients.
2002 Oct
[Long-memory of labor pain].
2002 Oct 14
Characterisation of silent and active genes for a variable large protein of Borrelia recurrentis.
2002 Oct 14
Two in one: patient-controlled epidural analgesia (PCEA) to prevent erection and control pain in adult hypospadias-surgery patients.
2002 Sep
Can ketamine potentiate the analgesic effect of epidural morphine, preincisional or postincisional administration?
2002 Sep
Effects of intravenous opioids on eye movements in humans: possible mechanisms.
2002 Sep
Retroperitoneal laparoscopic radical nephrectomy and nephroureterectomy and comparison with open surgery.
2002 Sep
Comparison of colonoscopies performed under sedation with propofol or with midazolam or without sedation.
2003
Demographics, assessment and management of pain in the elderly.
2003
Patents

Sample Use Guides

Oral: 50 to 100 mg every 4 hours as needed. IV,IM,subcutaneously: 25 to 100 mg every 4 hours as needed. Continuous IV: 15 to 35 mg/hr.
Route of Administration: Other
In Vitro Use Guide
Pethidine's stimulant action on the 22-day pregnant rat isolated uterus does not involve receptors sensitive to methysergide and is unlikely to involve the synthesis and release of endogenous prostaglandins. Maximal stimulant response occurred with 40 ug/ml.
Name Type Language
MEPERIDINE
HSDB   MI   VANDF  
Common Name English
PETHIDINE
INN   WHO-DD  
INN  
Official Name English
IDS-NP-001
Code English
MEPERIDINE [MI]
Common Name English
RENAUDIN
Common Name English
PETHANOL
Common Name English
4-PIPERIDINECARBOXYLIC ACID, 1-METHYL-4-PHENYL-, ETHYL ESTER
Common Name English
ETHYL 1-METHYL-4-PHENYLISONIPECOTATE
Systematic Name English
ISONIPECAINE
Common Name English
PETHIDINETER
Common Name English
ISONIPECOTIC ACID, 1-METHYL-4-PHENYL-, ETHYL ESTER
Systematic Name English
1-METHYL-4-PHENYLPIPERIDINE-4-CARBOXYLIC ACID ETHYL ESTER
Systematic Name English
MEPERIDINE [HSDB]
Common Name English
MEPERIDINE [VANDF]
Common Name English
MEPERIDOL
Common Name English
PETHIDINE DBL
Brand Name English
ETHYL 1-METHYL-4-PHENYLPIPERIDINE-4-CARBOXYLATE
Systematic Name English
Pethidine [WHO-DD]
Common Name English
pethidine [INN]
Common Name English
Classification Tree Code System Code
WHO-VATC QN02AG03
Created by admin on Thu Jul 06 23:23:25 UTC 2023 , Edited by admin on Thu Jul 06 23:23:25 UTC 2023
NCI_THESAURUS C67413
Created by admin on Thu Jul 06 23:23:25 UTC 2023 , Edited by admin on Thu Jul 06 23:23:25 UTC 2023
WHO-ATC N02AB72
Created by admin on Thu Jul 06 23:23:25 UTC 2023 , Edited by admin on Thu Jul 06 23:23:25 UTC 2023
LIVERTOX NBK548764
Created by admin on Thu Jul 06 23:23:25 UTC 2023 , Edited by admin on Thu Jul 06 23:23:25 UTC 2023
NDF-RT N0000175690
Created by admin on Thu Jul 06 23:23:25 UTC 2023 , Edited by admin on Thu Jul 06 23:23:25 UTC 2023
DEA NO. 9230
Created by admin on Thu Jul 06 23:23:25 UTC 2023 , Edited by admin on Thu Jul 06 23:23:25 UTC 2023
WHO-ATC N02AB52
Created by admin on Thu Jul 06 23:23:25 UTC 2023 , Edited by admin on Thu Jul 06 23:23:25 UTC 2023
NDF-RT N0000175684
Created by admin on Thu Jul 06 23:23:25 UTC 2023 , Edited by admin on Thu Jul 06 23:23:25 UTC 2023
WHO-VATC QN02AB72
Created by admin on Thu Jul 06 23:23:25 UTC 2023 , Edited by admin on Thu Jul 06 23:23:25 UTC 2023
WHO-VATC QN02AB02
Created by admin on Thu Jul 06 23:23:25 UTC 2023 , Edited by admin on Thu Jul 06 23:23:25 UTC 2023
WHO-ATC N02AB02
Created by admin on Thu Jul 06 23:23:25 UTC 2023 , Edited by admin on Thu Jul 06 23:23:25 UTC 2023
WHO-VATC QN02AB52
Created by admin on Thu Jul 06 23:23:25 UTC 2023 , Edited by admin on Thu Jul 06 23:23:25 UTC 2023
WHO-ATC N02AG03
Created by admin on Thu Jul 06 23:23:25 UTC 2023 , Edited by admin on Thu Jul 06 23:23:25 UTC 2023
Code System Code Type Description
EPA CompTox
DTXSID9023253
Created by admin on Thu Jul 06 23:23:25 UTC 2023 , Edited by admin on Thu Jul 06 23:23:25 UTC 2023
PRIMARY
RXCUI
6754
Created by admin on Thu Jul 06 23:23:25 UTC 2023 , Edited by admin on Thu Jul 06 23:23:25 UTC 2023
PRIMARY RxNorm
CAS
57-42-1
Created by admin on Thu Jul 06 23:23:25 UTC 2023 , Edited by admin on Thu Jul 06 23:23:25 UTC 2023
PRIMARY
SMS_ID
100000082223
Created by admin on Thu Jul 06 23:23:25 UTC 2023 , Edited by admin on Thu Jul 06 23:23:25 UTC 2023
PRIMARY
IUPHAR
7221
Created by admin on Thu Jul 06 23:23:25 UTC 2023 , Edited by admin on Thu Jul 06 23:23:25 UTC 2023
PRIMARY
INN
411
Created by admin on Thu Jul 06 23:23:25 UTC 2023 , Edited by admin on Thu Jul 06 23:23:25 UTC 2023
PRIMARY
ECHA (EC/EINECS)
200-329-1
Created by admin on Thu Jul 06 23:23:25 UTC 2023 , Edited by admin on Thu Jul 06 23:23:25 UTC 2023
PRIMARY
WIKIPEDIA
PETHIDINE
Created by admin on Thu Jul 06 23:23:25 UTC 2023 , Edited by admin on Thu Jul 06 23:23:25 UTC 2023
PRIMARY
DRUG BANK
DB00454
Created by admin on Thu Jul 06 23:23:25 UTC 2023 , Edited by admin on Thu Jul 06 23:23:25 UTC 2023
PRIMARY
LACTMED
Meperidine
Created by admin on Thu Jul 06 23:23:25 UTC 2023 , Edited by admin on Thu Jul 06 23:23:25 UTC 2023
PRIMARY
PUBCHEM
4058
Created by admin on Thu Jul 06 23:23:25 UTC 2023 , Edited by admin on Thu Jul 06 23:23:25 UTC 2023
PRIMARY
ChEMBL
CHEMBL607
Created by admin on Thu Jul 06 23:23:25 UTC 2023 , Edited by admin on Thu Jul 06 23:23:25 UTC 2023
PRIMARY
MESH
D008614
Created by admin on Thu Jul 06 23:23:25 UTC 2023 , Edited by admin on Thu Jul 06 23:23:25 UTC 2023
PRIMARY
NCI_THESAURUS
C71632
Created by admin on Thu Jul 06 23:23:25 UTC 2023 , Edited by admin on Thu Jul 06 23:23:25 UTC 2023
PRIMARY
DAILYMED
9E338QE28F
Created by admin on Thu Jul 06 23:23:25 UTC 2023 , Edited by admin on Thu Jul 06 23:23:25 UTC 2023
PRIMARY
FDA UNII
9E338QE28F
Created by admin on Thu Jul 06 23:23:25 UTC 2023 , Edited by admin on Thu Jul 06 23:23:25 UTC 2023
PRIMARY
HSDB
3116
Created by admin on Thu Jul 06 23:23:25 UTC 2023 , Edited by admin on Thu Jul 06 23:23:25 UTC 2023
PRIMARY
EVMPD
SUB09738MIG
Created by admin on Thu Jul 06 23:23:25 UTC 2023 , Edited by admin on Thu Jul 06 23:23:25 UTC 2023
PRIMARY
MERCK INDEX
M7186
Created by admin on Thu Jul 06 23:23:25 UTC 2023 , Edited by admin on Thu Jul 06 23:23:25 UTC 2023
PRIMARY Merck Index
DRUG CENTRAL
1690
Created by admin on Thu Jul 06 23:23:25 UTC 2023 , Edited by admin on Thu Jul 06 23:23:25 UTC 2023
PRIMARY
CHEBI
6754
Created by admin on Thu Jul 06 23:23:25 UTC 2023 , Edited by admin on Thu Jul 06 23:23:25 UTC 2023
PRIMARY